| __timestamp | United Therapeutics Corporation | Viridian Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 381287000 | 7751000 |
| Thursday, January 1, 2015 | 452612000 | 10251000 |
| Friday, January 1, 2016 | 316800000 | 9575000 |
| Sunday, January 1, 2017 | 330100000 | 10912000 |
| Monday, January 1, 2018 | 265800000 | 11049000 |
| Tuesday, January 1, 2019 | 336200000 | 11646000 |
| Wednesday, January 1, 2020 | 423900000 | 13265000 |
| Friday, January 1, 2021 | 467000000 | 25805000 |
| Saturday, January 1, 2022 | 487000000 | 35182000 |
| Sunday, January 1, 2023 | 477100000 | 94999000 |
Unleashing the power of data
In the competitive world of biotechnology, managing operational costs is crucial for success. United Therapeutics Corporation and Viridian Therapeutics, Inc. offer a fascinating study in contrasts over the past decade. From 2014 to 2023, United Therapeutics consistently demonstrated robust SG&A efficiency, with expenses peaking at approximately $487 million in 2022. This represents a steady increase of around 28% from 2014. In contrast, Viridian Therapeutics, while starting with significantly lower SG&A expenses, saw a dramatic rise of over 1,100%, reaching nearly $95 million by 2023. This surge reflects Viridian's aggressive growth strategy and expansion efforts. The data underscores the importance of strategic financial management in the biotech sector, where balancing growth and efficiency can dictate market leadership. As these companies continue to evolve, their SG&A strategies will remain pivotal in shaping their competitive edge.
Who Optimizes SG&A Costs Better? Sanofi or Viridian Therapeutics, Inc.
Gilead Sciences, Inc. vs United Therapeutics Corporation: SG&A Expense Trends
Operational Costs Compared: SG&A Analysis of United Therapeutics Corporation and Genmab A/S
United Therapeutics Corporation and Bio-Techne Corporation: SG&A Spending Patterns Compared
Breaking Down SG&A Expenses: United Therapeutics Corporation vs Lantheus Holdings, Inc.
SG&A Efficiency Analysis: Comparing United Therapeutics Corporation and Catalyst Pharmaceuticals, Inc.
Comparing SG&A Expenses: United Therapeutics Corporation vs Bausch Health Companies Inc. Trends and Insights
United Therapeutics Corporation vs Vericel Corporation: SG&A Expense Trends
United Therapeutics Corporation vs Xencor, Inc.: SG&A Expense Trends
Operational Costs Compared: SG&A Analysis of CRISPR Therapeutics AG and Viridian Therapeutics, Inc.
SG&A Efficiency Analysis: Comparing Amicus Therapeutics, Inc. and Viridian Therapeutics, Inc.
Operational Costs Compared: SG&A Analysis of HUTCHMED (China) Limited and Viridian Therapeutics, Inc.